BUSINESS: Global Neurology Clinical Trials Market (2021 To 2028) – Featuring IQVIA, Novartis And Covance Among Others
| | | | | | | | | | | | | | | | |

BUSINESS: Global Neurology Clinical Trials Market (2021 To 2028) – Featuring IQVIA, Novartis And Covance Among Others

Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) — The “Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication, By Region, and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. The global neurology clinical trials…

BUSINESS: Neurology Clinical Trials Market Size Worth $7.4 Billion By 2028: Grand View Research, Inc.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Neurology Clinical Trials Market Size Worth $7.4 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, Oct. 14, 2021 /PRNewswire/ — The global neurology clinical trials market size is expected to reach USD 7.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. This is largely attributed to big pharma…

End of content

End of content